Justin I Odegaard Selected Research

Justin I Odegaard Research Topics

Disease

15	Neoplasms (Cancer) 01/2022 - 01/2012
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 12/2017
5	Inflammation (Inflammations) 01/2019 - 07/2006
4	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2018
4	Stomach Neoplasms (Stomach Cancer) 10/2021 - 01/2018
3	Schistosomiasis haematobia (Schistosomiasis haematobium) 01/2020 - 01/2015
3	Hemorrhage 01/2019 - 01/2015
3	Hemorrhagic Cystitis 01/2019 - 01/2018
3	Fibrosis (Cirrhosis) 01/2015 - 01/2012
3	Obesity 06/2014 - 06/2007
2	Microsatellite Instability 12/2019 - 01/2018
2	Pain (Aches) 01/2019 - 01/2018
2	Infections 04/2016 - 12/2010
2	Insulin Resistance 06/2008 - 06/2007
1	Neoplasm Metastasis (Metastasis) 08/2021
1	Breast Neoplasms (Breast Cancer) 02/2021
1	Urinary Tract Infections (Urinary Tract Infection) 12/2020
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 12/2020
1	Disease Progression 01/2020
1	Hyperplasia 01/2020
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020
1	Colonic Neoplasms (Colon Cancer) 01/2019
1	Cystitis 01/2019
1	Schistosomiasis (Bilharziasis) 01/2019
1	Coinfection 03/2018
1	Virus Diseases (Viral Diseases) 03/2018
1	Urinary Bladder Diseases (Bladder Diseases) 01/2018
1	Granuloma 01/2015
1	Wounds and Injuries (Trauma) 01/2015
1	Weight Loss (Weight Reduction) 01/2015
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 10/2014
1	Leukemia 07/2014
1	Ameloblastoma 07/2014
1	Odontogenic Tumors (Dental Tissue Neoplasm) 07/2014
1	Tendinopathy (Tendonitis) 06/2012
1	Carcinogenesis 01/2012
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2009
1	Kidney Diseases (Kidney Disease) 11/2009
1	Glucose Intolerance 06/2007

Drug/Important Bio-Agent (IBA)

11	Circulating Tumor DNAIBA 01/2022 - 01/2018
7	Cell-Free Nucleic AcidsIBA 01/2022 - 12/2017
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 06/2014
5	Interleukin-4 (Interleukin 4)IBA 01/2019 - 12/2010
4	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 12/2017
2	Mesna (Coenzyme M)FDA LinkGeneric 01/2019 - 01/2018
2	Ifosfamide FDA LinkGeneric 01/2019 - 01/2018
2	ChemokinesIBA 01/2015 - 06/2007
1	pertuzumabIBA 11/2021
1	Trastuzumab (Herceptin)FDA Link 11/2021
1	human ERBB2 proteinIBA 11/2021
1	Peptides (Polypeptides)IBA 12/2020
1	Hormones (Hormone)IBA 01/2020
1	AlpelisibIBA 01/2020
1	CarcinogensIBA 01/2020
1	Estrogen Receptor Modulators (Antiestrogen)IBA 01/2020
1	Aromatase InhibitorsIBA 01/2020
1	1- (1- (imidazo(1,2- a)pyridin- 6- yl)ethyl)- 6- (1- methyl- 1H- pyrazol- 4- yl)- 1H- (1,2,3)triazolo(4,5- b)pyrazineIBA 10/2019
1	Pregnenolone Carbonitrile (PCN)IBA 01/2019
1	osimertinibIBA 01/2019
1	Acrolein (Aqualin)IBA 01/2019
1	Immunoglobulin E (IgE)IBA 01/2019
1	B7-H1 AntigenIBA 01/2018
1	pembrolizumabIBA 01/2018
1	ResistinIBA 04/2016
1	SolutionsIBA 01/2016
1	Liposomes (Liposome)IBA 01/2015
1	Clodronic Acid (Clodronate)IBA 01/2015
1	Heterophile AntigensIBA 01/2015
1	CalciumIBA 10/2014
1	Pharmaceutical PreparationsIBA 07/2014
1	VemurafenibIBA 07/2014
1	Mitogen-Activated Protein KinasesIBA 07/2014
1	Arsenic Trioxide (Trisenox)FDA Link 07/2014
1	Hematoxylin (Haematoxylon)IBA 06/2012
1	Eosine Yellowish-(YS) (Eosin)IBA 06/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2012
1	CollagenIBA 01/2012
1	Metalloproteases (Metalloproteinases)IBA 01/2012
1	Insulin (Novolin)FDA Link 12/2010
1	Glucose (Dextrose)FDA LinkGeneric 12/2010
1	AutoantibodiesIBA 11/2009
1	PPAR deltaIBA 06/2008
1	CCR2 ReceptorsIBA 06/2007
1	PPAR gammaIBA 06/2007
1	LigandsIBA 06/2007
1	CytokinesIBA 07/2006

Therapy/Procedure

8	Therapeutics 01/2022 - 07/2006
3	Drug Therapy (Chemotherapy) 10/2021 - 01/2018
1	Hepatectomy 08/2021
1	Immunotherapy 12/2019
1	Cell Transplantation 03/2018
1	Injections 06/2012